Compare VOR & CGNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VOR | CGNT |
|---|---|---|
| Founded | 2015 | 2020 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 934.7M | 768.2M |
| IPO Year | 2021 | 2020 |
| Metric | VOR | CGNT |
|---|---|---|
| Price | $14.67 | $9.67 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 3 |
| Target Price | ★ $45.33 | $13.50 |
| AVG Volume (30 Days) | ★ 892.8K | 614.0K |
| Earning Date | 05-11-2026 | 06-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $13.73 |
| Revenue Next Year | N/A | $10.45 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.17 | $6.29 |
| 52 Week High | $49.95 | $11.66 |
| Indicator | VOR | CGNT |
|---|---|---|
| Relative Strength Index (RSI) | 46.02 | 49.05 |
| Support Level | $11.74 | $8.02 |
| Resistance Level | $14.73 | $9.75 |
| Average True Range (ATR) | 0.97 | 0.47 |
| MACD | -0.03 | -0.11 |
| Stochastic Oscillator | 21.21 | 20.26 |
Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.
Cognyte Software Ltd provides security analytics software that empowers governments and enterprises with Actionable Intelligence. Its interface software is designed to help customers accelerate and improve the effectiveness of investigations and decision-making.